Refining AML Treatment: The Role of Genetics in Response and Resistance Evaluation to New Agents

SIMPLE SUMMARY: Acute myeloid leukemia (AML) is an aggressive cancer of the hematopoietic system. At present, we know that AML is heterogeneous and varies from one patient to another, often characterized by specific changes in the DNA (mutations). Likewise, we know that the mutational landscape of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Halik, Adriane, Arends, Christopher Maximilian, Bullinger, Lars, Damm, Frederik, Frick, Mareike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996853/
https://www.ncbi.nlm.nih.gov/pubmed/35406464
http://dx.doi.org/10.3390/cancers14071689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996853/
https://www.ncbi.nlm.nih.gov/pubmed/35406464
http://dx.doi.org/10.3390/cancers14071689

Ejemplares similares